NCT06575010View on ClinicalTrials.gov

Exparel v Dexamethasone in RCR

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

August 26, 2024

Primary Completion Date

August 30, 2025

Study Completion Date

August 30, 2025

Conditions
Rotator Cuff TearsPostoperative Pain
Interventions
DRUG

Liposomal bupivacaine

20 mL Liposomal bupivacaine (Exparel) will be given in the shoulder block prior to surgery

DRUG

Bupivacaine Hcl 0.5% Inj

0.75% bupivacaine will be given in the shoulder block prior to surgery

DRUG

Dexamethasone

10 mg Dexamethasone will be given in the shoulder block prior to surgery

Trial Locations (1)

19107

Rothman Orthopaedic Institute, Philadelphia

All Listed Sponsors
lead

Rothman Institute Orthopaedics

OTHER